参考资料: [1]NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Breast Cancer, Version 1.2024, January 25, 2024. [2]NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Breast Cancer, Version 2.2024, March 11, 2024. [3]NCCN Clinical Practice Guidelines in Oncolo...
[1]NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Breast Cancer, Version 6.2024, November 11, 2024. [2]Turner NC, Im SA, Saura C, et al. Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer. N Engl J Med. 2024 Oct 31;391(17):1584-1596. 精彩资讯等...
参考文献: [1]NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Breast Cancer, Version 6.2024, November 11, 2024. [2]Turner NC, Im SA, Saura C, et al. Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast...
2024 v3版的NCCN指南1中,HR+/HER2-晚期乳腺癌一线治疗中瑞波西利无论是联合芳香化酶抑制剂(AI)还是氟维司群均为1类推荐,其中瑞波西利是与AI联合用于HR+/HER2- 晚期乳腺癌一线治疗唯一获得1类推荐的CDK4/6抑制剂,这与2023年NCCN指南...
Adjuvant Ribociclib (RIB) Plus Nonsteroidal Aromatase Inhibitor (NSAI) in Patients (Pts) With HR+/HER2− Early Breast Cancer (EBC): 4-Year Outcomes From the NATALEE Trial. LBA13. Proffered Paper presented at the European Society for Medical Oncology Congress; September 16, 2024; Barcelona,...
PRINCIPLES OF DEDICATED BREAST MRI TESTING See NCCN Guidelines for Breast Cancer Screening and Diagnosis for indications for screening MRI in women at increased breast cancer risk. 乳腺专用的MRI检查的原则见NCCN乳腺癌筛查与诊断指南关于在乳腺癌风险增加的女性中MRI筛检指征。
Stage IV Metastatic or Recurrent Breast Cancer Staging and Workup IV期转移性或复发性乳腺癌的分期和检查 The staging evaluation of women who present with metastatic or recurrent breast cancer includes history and physical exam; the performance of a CBC, liver function tests, chest diagnostic CT, bon...
RVM场EKMiSinVM,H0DM?C?MVW4Cm MM* National Comprehensive CancerNetwork*NCCN Guidelines Version 2.2021 Invasive Breast CancorNCCN l/tfWitYahto PiwgotADJUVANT ENDOCRINE THERAPYatLlArorTMrtiw inhibitor for S/(c?gcry 1) PostnvnopausaT1 —* orFunacHo* fb s y (cMQory 1)| / ICoEdtr tomoxifm...
- NCCN Guidelines Version4.2020 NCCN Guidelines Index Tableof Contents Invasive Breast Cancer Discussion 组织学 激素 HER2 状态 b 系统辅助治疗 受体状态 参见全身辅助治疗:激素受体阳性-HER2 阳性疾病 (BINV-5) HER2 阳性 ebb ER-阳性峰,cc 和/或 参见全身辅助治疗:淋巴结阴性-激素受体阳性-HER2 阴性疾病 ...
Adjuvant Ribociclib (RIB) Plus Nonsteroidal Aromatase Inhibitor (NSAI) in Patients (Pts) With HR+/HER2− Early Breast Cancer (EBC): 4-Year Outcomes From the NATALEE Trial. LBA13. Proffered Paper presented at the European Society...